CELL & GENE MEETING ON THE MESA 2021 NEWS
Precision Advance aims to improve patient access to cell and gene therapy
October 14, 2021 -- Improving patient access to cell and gene therapy treatments is the goal of Precision Advance, an initiative of Precision Medicine Group. Precision Advance provides a set of interconnected services and personnel designed to help bring new therapies to market.
October 14, 2021 -- Improving patient access to cell and gene therapy treatments is the goal of Precision Advance, an initiative of Precision Medicine Group. Precision Advance provides a set of interconnected services and personnel designed to help bring new therapies to market.
Dialogue with regulators will help bring cell and gene therapies to market
October 13, 2021 -- CARLSBAD, CA - Open engagement and frequent communication with regulators is needed throughout the development process for cell and gene therapies to help bring them to market, according to an October 13 session at the Cell & Gene Meeting on the Mesa.
October 13, 2021 -- CARLSBAD, CA - Open engagement and frequent communication with regulators is needed throughout the development process for cell and gene therapies to help bring them to market, according to an October 13 session at the Cell & Gene Meeting on the Mesa.
Catching up with the Alliance for Regenerative Medicine at Cell & Gene Meeting on the Mesa
October 13, 2021 -- CARLSBAD, CA - What's going on at this week's Cell & Gene Meeting on the Mesa? ScienceBoard.net spoke with Stephen Majors, director of public affairs at the Alliance for Regenerative Medicine, who shared what's being discussed at this year's meeting.
October 13, 2021 -- CARLSBAD, CA - What's going on at this week's Cell & Gene Meeting on the Mesa? ScienceBoard.net spoke with Stephen Majors, director of public affairs at the Alliance for Regenerative Medicine, who shared what's being discussed at this year's meeting.
What's next for cellular immunotherapies?
October 13, 2021 -- CARLSBAD, CA - What's the next step in the development of cellular immunotherapies, particularly for liquid and solid tumors? At this week's Cell & Gene Meeting on the Mesa, Dr. Kanya Rajangam, PhD, of Nkarta Therapeutics explained the latest approaches.
October 13, 2021 -- CARLSBAD, CA - What's the next step in the development of cellular immunotherapies, particularly for liquid and solid tumors? At this week's Cell & Gene Meeting on the Mesa, Dr. Kanya Rajangam, PhD, of Nkarta Therapeutics explained the latest approaches.
MilliporeSigma speaks with ScienceBoard at Cell & Gene Meeting on the Mesa
October 12, 2021 -- ScienceBoard.net spoke with Jerry Kebyl, PhD, senior director of cell and gene therapy at MilliporeSigma recently at the Cell and Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine in Carlsbad, CA.
October 12, 2021 -- ScienceBoard.net spoke with Jerry Kebyl, PhD, senior director of cell and gene therapy at MilliporeSigma recently at the Cell and Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine in Carlsbad, CA.
Mission Bio speaks with ScienceBoard at Cell & Gene Meeting on the Mesa
October 12, 2021 -- ScienceBoard.net spoke with Nori Ueno, PhD, associate director of business development - cell and gene therapy at Mission Bio recently at the Cell and Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine in Carlsbad, CA.
October 12, 2021 -- ScienceBoard.net spoke with Nori Ueno, PhD, associate director of business development - cell and gene therapy at Mission Bio recently at the Cell and Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine in Carlsbad, CA.
Meeting on the Mesa ramps up rules on COVID-19 vaccination, testing
August 24, 2021 -- The Alliance for Regenerative Medicine has implemented new rules for its Cell & Gene Meeting on the Mesa, which is scheduled for October 12-14, 2021, that require attendees to either provide proof of vaccination from COVID-19 or a negative COVID test.
August 24, 2021 -- The Alliance for Regenerative Medicine has implemented new rules for its Cell & Gene Meeting on the Mesa, which is scheduled for October 12-14, 2021, that require attendees to either provide proof of vaccination from COVID-19 or a negative COVID test.